Moderna (MRNA)

R&D Expense Growth

0.31%

Quarterly · Period ending:

MRNA logo

MRNA R&D Expense Growth

Latest reported0.31%
MRNA Quarterly R&D Growth (QoQ) (0.00% → 0.31%)
High-resolution chart · PNG

MRNA r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Moderna R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
0.3082%
-16.2581%
-3.2459%
14.4286%
-18.2243%
-23.7077%
-1.3193%
-6.8796%
18.89%
-26.9559%
21.2069%
1.0453%
1.5031%
-6.6061%
47.6829%
15.493%
28.1588%
-14.5062%
24.3762%
23.753%
4.9875%
-47.1576%
120.2876%
126.8504%
31.8916%
-2.0302%
-1.831%
-6.8337%
-1.5922%
-13.1983%
37.945%
4.375%
15.9281%
-23.5116%
25.8661%
-5.9256%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.